Skip to main content
Top
Published in: Virology Journal 1/2019

Open Access 01-12-2019 | Zanamivir | Research

Roles of the highly conserved amino acids in the second receptor binding site of the Newcastle disease virus HN protein

Authors: Yaqing Liu, Miaomiao Chi, Ying Liu, Hongling Wen, Li Zhao, Yanyan Song, Na Liu, Zhiyu Wang

Published in: Virology Journal | Issue 1/2019

Login to get access

Abstract

Background

The paramyxovirus haemagglutinin-neuraminidase (HN) is a multifunctional protein that is responsible for attachment to receptors, removal of receptors from infected cells to prevent viral self-aggregation (neuraminidase, NA) and fusion promotion. It is commonly accepted that there are two receptor binding sites in the globular head of HN, and the second receptor binding site is only involved in the function of receptor binding and fusion promotion.

Methods

10 conserved residues in the second receptor binding site of Newcastle disease virus (NDV) HN were chosen and substituted to alanine (A). The desired mutants were examined to detect the functional change in hemadsorption (HAD) ability, NA activity and fusion promotion ability.

Results

The HAD and fusion promotion ability of mutants C172A, R174A, C196A, D198A, Y526A and E547A were abolished. Compared with wild-type (wt) HN, the HAD of mutants T167A, S202A and R516A decreased to 55.81, 44.53, 69.02%, respectively, and the fusion promotion ability of these three mutants decreased to 54.74, 49.46, 65.26%, respectively; however, mutant G171A still maintained fusion promotion ability comparable with wt HN but had impaired HAD ability. All the site-directed mutations altered the NA activity of NDV HN without affecting protein cell surface expression.

Conclusions

The data suggest that mutants C172A, R174A, C196A, D198A, Y526A and E547A do not allow the conformational change that is required for fusion promotion ability and HAD activity, while the other mutants only affect the conformational change to a limited extent, except mutant G171A with intact fusion promotion ability. Overall, the conserved amino acids in the second receptor binding site, especially residues C172, R174, C196, D198, Y526 and E547, are crucial to normal NDV HN protein function.
Literature
1.
go back to reference Pawelczyk M, Kowalski ML. The role of human Parainfluenza virus infections in the immunopathology of the respiratory tract. Curr Allergy Asthma Rep. 2017;17(3):16.CrossRef Pawelczyk M, Kowalski ML. The role of human Parainfluenza virus infections in the immunopathology of the respiratory tract. Curr Allergy Asthma Rep. 2017;17(3):16.CrossRef
2.
go back to reference Clayton BA. Nipah virus: transmission of a zoonotic paramyxovirus. Curr Opin Virol. 2017;22:97–104.CrossRef Clayton BA. Nipah virus: transmission of a zoonotic paramyxovirus. Curr Opin Virol. 2017;22:97–104.CrossRef
3.
go back to reference Bajimaya S, Hayashi T, Takimoto T. Rescue of Sendai virus from Cloned cDNA. Methods Mol Biol (Clifton, NJ). 2017;1602:103–10.CrossRef Bajimaya S, Hayashi T, Takimoto T. Rescue of Sendai virus from Cloned cDNA. Methods Mol Biol (Clifton, NJ). 2017;1602:103–10.CrossRef
4.
go back to reference Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP. Molecular biology, pathogenesis and pathology of mumps virus. J Pathol. 2015;235(2):242–52.CrossRef Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP. Molecular biology, pathogenesis and pathology of mumps virus. J Pathol. 2015;235(2):242–52.CrossRef
5.
go back to reference Liu Y, Sun C, Chi M, Wen H, Zhao L, Song Y, Liu N, Wang Z. Genetic characterization and phylogenetic analysis of Newcastle disease virus from China. Infect Genet Evol. 2019;75:103958.CrossRef Liu Y, Sun C, Chi M, Wen H, Zhao L, Song Y, Liu N, Wang Z. Genetic characterization and phylogenetic analysis of Newcastle disease virus from China. Infect Genet Evol. 2019;75:103958.CrossRef
6.
go back to reference Smith EC, Popa A, Chang A, Masante C, Dutch RE. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 2009;276(24):7217–27.CrossRef Smith EC, Popa A, Chang A, Masante C, Dutch RE. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 2009;276(24):7217–27.CrossRef
7.
go back to reference Lamb RA, Paterson RG, Jardetzky TS. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology. 2006;344(1):30–7.CrossRef Lamb RA, Paterson RG, Jardetzky TS. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology. 2006;344(1):30–7.CrossRef
8.
go back to reference Li J, Quinlan E, Mirza A, Iorio RM. Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion. J Virol. 2004;78(10):5299–310.CrossRef Li J, Quinlan E, Mirza A, Iorio RM. Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion. J Virol. 2004;78(10):5299–310.CrossRef
9.
go back to reference Porotto M, Devito I, Palmer SG, Jurgens EM, Yee JL, Yokoyama CC, Pessi A, Moscona A. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. J Virol. 2011;85(24):12867–80.CrossRef Porotto M, Devito I, Palmer SG, Jurgens EM, Yee JL, Yokoyama CC, Pessi A, Moscona A. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. J Virol. 2011;85(24):12867–80.CrossRef
10.
go back to reference Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, Portner A, Taylor G. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol. 2004;78(7):3733–41.CrossRef Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, Portner A, Taylor G. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol. 2004;78(7):3733–41.CrossRef
11.
go back to reference Langedijk JP, Daus FJ, van Oirschot JT. Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol. 1997;71(8):6155–67.PubMedPubMedCentral Langedijk JP, Daus FJ, van Oirschot JT. Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol. 1997;71(8):6155–67.PubMedPubMedCentral
12.
go back to reference Portner A, Scroggs RA, Metzger DW. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology. 1987;158(1):61–8.CrossRef Portner A, Scroggs RA, Metzger DW. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology. 1987;158(1):61–8.CrossRef
13.
go back to reference Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol. 2000;7(11):1068–74.CrossRef Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol. 2000;7(11):1068–74.CrossRef
14.
go back to reference Merz DC, Prehm P, Scheid A, Choppin PW. Inhibition of the neuraminidase of paramyxoviruses by halide ions: a possible means of modulating the two activities of the HN protein. Virology. 1981;112(1):296–305.CrossRef Merz DC, Prehm P, Scheid A, Choppin PW. Inhibition of the neuraminidase of paramyxoviruses by halide ions: a possible means of modulating the two activities of the HN protein. Virology. 1981;112(1):296–305.CrossRef
15.
go back to reference Porotto M, Fornabaio M, Greengard O, Murrell MT, Kellogg GE, Moscona A. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site. J Virol. 2006;80(3):1204–13.CrossRef Porotto M, Fornabaio M, Greengard O, Murrell MT, Kellogg GE, Moscona A. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site. J Virol. 2006;80(3):1204–13.CrossRef
16.
go back to reference Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J Virol. 2002;76(24):13028–33.CrossRef Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J Virol. 2002;76(24):13028–33.CrossRef
17.
go back to reference Porotto M, Fornabaio M, Kellogg GE, Moscona A. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J Virol. 2007;81(7):3216–28.CrossRef Porotto M, Fornabaio M, Kellogg GE, Moscona A. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J Virol. 2007;81(7):3216–28.CrossRef
18.
go back to reference Mishin VP, Watanabe M, Taylor G, Devincenzo J, Bose M, Portner A, Alymova IV. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. J Virol. 2010;84(6):3094–100.CrossRef Mishin VP, Watanabe M, Taylor G, Devincenzo J, Bose M, Portner A, Alymova IV. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. J Virol. 2010;84(6):3094–100.CrossRef
19.
go back to reference Navaratnarajah CK, Oezguen N, Rupp L, Kay L, Leonard VH, Braun W, Cattaneo R. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol. 2011;18(2):128–34.CrossRef Navaratnarajah CK, Oezguen N, Rupp L, Kay L, Leonard VH, Braun W, Cattaneo R. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol. 2011;18(2):128–34.CrossRef
20.
go back to reference Jardetzky TS, Lamb RA. Activation of paramyxovirus membrane fusion and virus entry. Curr Opin Virol. 2014;5:24–33.CrossRef Jardetzky TS, Lamb RA. Activation of paramyxovirus membrane fusion and virus entry. Curr Opin Virol. 2014;5:24–33.CrossRef
21.
go back to reference Bagai S, Lamb RA. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol. 1995;69(11):6712–9.PubMedPubMedCentral Bagai S, Lamb RA. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol. 1995;69(11):6712–9.PubMedPubMedCentral
22.
go back to reference Melanson VR, Iorio RM. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J Virol. 2006;80(2):623–33.CrossRef Melanson VR, Iorio RM. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J Virol. 2006;80(2):623–33.CrossRef
23.
go back to reference Porotto M, Salah Z, DeVito I, Talekar A, Palmer SG, Xu R, Wilson IA, Moscona A. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion. J Virol. 2012;86(10):5730–41.CrossRef Porotto M, Salah Z, DeVito I, Talekar A, Palmer SG, Xu R, Wilson IA, Moscona A. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion. J Virol. 2012;86(10):5730–41.CrossRef
24.
go back to reference Connaris H, Takimoto T, Russell R, Crennell S, Moustafa I, Portner A, Taylor G. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. J Virol. 2002;76(4):1816–24.CrossRef Connaris H, Takimoto T, Russell R, Crennell S, Moustafa I, Portner A, Taylor G. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. J Virol. 2002;76(4):1816–24.CrossRef
25.
go back to reference Xie W, Wen H, Chu F, Yan S, Lin B, Xie W, Liu Y, Ren G, Zhao L, Song Y, Sun C, Wang Z. Mutations in the DI-DII linker of human Parainfluenza virus type 3 fusion protein result in diminished fusion activity. PLoS One. 2015;10(8):e0136474.CrossRef Xie W, Wen H, Chu F, Yan S, Lin B, Xie W, Liu Y, Ren G, Zhao L, Song Y, Sun C, Wang Z. Mutations in the DI-DII linker of human Parainfluenza virus type 3 fusion protein result in diminished fusion activity. PLoS One. 2015;10(8):e0136474.CrossRef
26.
go back to reference Guillaume V, Aslan H, Ainouze M, Guerbois M, Wild TF, Buckland R, Langedijk JP. Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model. J Virol. 2006;80(15):7546–54.CrossRef Guillaume V, Aslan H, Ainouze M, Guerbois M, Wild TF, Buckland R, Langedijk JP. Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model. J Virol. 2006;80(15):7546–54.CrossRef
27.
go back to reference Talekar A, Moscona A, Porotto M. Measles virus fusion machinery activated by sialic acid binding globular domain. J Virol. 2013;87(24):13619–27.CrossRef Talekar A, Moscona A, Porotto M. Measles virus fusion machinery activated by sialic acid binding globular domain. J Virol. 2013;87(24):13619–27.CrossRef
28.
go back to reference Mahon PJ, Mirza AM, Iorio RM. Role of the two sialic acid binding sites on the Newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion. J Virol. 2011;85(22):12079–82.CrossRef Mahon PJ, Mirza AM, Iorio RM. Role of the two sialic acid binding sites on the Newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion. J Virol. 2011;85(22):12079–82.CrossRef
29.
go back to reference Sun C, Wen H, Chen Y, Chu F, Lin B, Ren G, Song Y, Wang Z. Roles of the highly conserved amino acids in the globular head and stalk region of the Newcastle disease virus HN protein in the membrane fusion process. Biosci Trends. 2015;9(1):56–64.CrossRef Sun C, Wen H, Chen Y, Chu F, Lin B, Ren G, Song Y, Wang Z. Roles of the highly conserved amino acids in the globular head and stalk region of the Newcastle disease virus HN protein in the membrane fusion process. Biosci Trends. 2015;9(1):56–64.CrossRef
30.
go back to reference Deng R, Wang Z, Mahon PJ, Marinello M, Mirza A, Iorio RM. Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion. Virology. 1999;253(1):43–54.CrossRef Deng R, Wang Z, Mahon PJ, Marinello M, Mirza A, Iorio RM. Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion. Virology. 1999;253(1):43–54.CrossRef
Metadata
Title
Roles of the highly conserved amino acids in the second receptor binding site of the Newcastle disease virus HN protein
Authors
Yaqing Liu
Miaomiao Chi
Ying Liu
Hongling Wen
Li Zhao
Yanyan Song
Na Liu
Zhiyu Wang
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Zanamivir
Published in
Virology Journal / Issue 1/2019
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-019-1273-y

Other articles of this Issue 1/2019

Virology Journal 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.